Hélène Cavé
Délégation Paris 5(FR)Inserm(FR)Inserm(FR)Délégation Paris 7(FR)Institut Universitaire de France(FR)Université Paris Cité(FR)Sorbonne Paris Cité(FR)Assistance Publique – Hôpitaux de Paris(FR)Assistance Publique – Hôpitaux de Paris(FR)Hôpital Robert-Debré(FR)
Publications by Year
Research Areas
Acute Lymphoblastic Leukemia research, Protein Tyrosine Phosphatases, Acute Myeloid Leukemia Research, Chronic Myeloid Leukemia Treatments, Galectins and Cancer Biology
Most-Cited Works
- → Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia – A Europe Against Cancer Program(2003)1,520 cited
- → Clinical Significance of Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia(1998)773 cited
- → Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data(2007)695 cited
- → The MLL recombinome of acute leukemias in 2017(2017)679 cited
- → Activating Mutations in theABCC8Gene in Neonatal Diabetes Mellitus(2006)630 cited
- → Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome(2006)598 cited